about
Metabolic endotoxemia: a molecular link between obesity and cardiovascular riskTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyGhrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle.Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryPhysiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscleGhrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia.Determinants of clinical improvement after surgical replacement or transcatheter aortic valve implantation for isolated aortic stenosisDiastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes.Rationale, design and methodology for Intraventricular Pressure Gradients Study: a novel approach for ventricular filling assessment in normal and falling heartsThe role of a structured exercise training program on cardiac structure and function after acute myocardial infarction: study protocol for a randomized controlled trialAngiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.Remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trialThe Effect of Exercise Training on Diastolic and Systolic Function After Acute Myocardial Infarction: A Randomized Study.How to use and integrate bioinformatics tools to compare proteomic data from distinct conditions? A tutorial using the pathological similarities between Aortic Valve Stenosis and Coronary Artery Disease as a case-study.Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.Cardiac venous arterialization in acute myocardial infarction: how great is the benefit?Physiological, pathological and potential therapeutic roles of ghrelin.Cardiac, skeletal, and smooth muscle regulation by ghrelin.The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications.Immunomodulatory role of thymulin in lung diseases.Toll-like receptors as therapeutic targets in gastrointestinal diseases.New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy.Hypertension and angiogenesis in the aging kidney: a review.The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.The role of titin in the modulation of cardiac function and its pathophysiological implications.Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.Current pathophysiological concepts and management of pulmonary hypertension.Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.Heart failure with preserved ejection fraction: fighting misconceptions for a new approach.Left intraventricular diastolic and systolic pressure gradients.Understanding the molecular and cellular changes behind aortic valve stenosis.Left ventricular hypertrophy in isolated aortic stenosis: primetime for the ventricle.Rodent models of heart failure: an updated review.Physiological, pathological and potential therapeutic roles of adipokines.Therapeutic potential of neuregulin-1 in cardiovascular disease.Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.Myocardial remote ischemic preconditioning: from pathophysiology to clinical application.Surgical treatment of atrial fibrillation: an updated review.Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.
P50
Q27023488-EF980582-EC1E-4278-A12F-9876E06EDD19Q27024879-F0B88E5A-6EE5-4790-BD7A-F0FD6347EC91Q33345416-E0D1DE53-2BB7-4ECB-A6E9-8EE204AC068CQ33755419-C0DA934C-B0AA-4850-A7E9-F87AB4AB0841Q33961078-4FEB69ED-C31D-4AF0-93FE-39FB6D870133Q33994274-0F753DD6-B93C-4699-8BE2-2CA88E9AEF7FQ34340189-B751F928-4B83-4E14-B72F-AAC4A63C3AB7Q34984569-6D7A078D-DD05-4387-AA16-08E6903AD0C6Q35005807-15FD52AC-EB6D-4633-93A3-2C59732F8E84Q35177237-EA670142-1142-4FD2-B467-26016956213CQ35545375-05A41D09-1BEF-4C85-9F43-2F3AADABB453Q36040821-C3ED0DE1-59BD-4C68-B78F-7C9692189F7FQ36194983-57F61612-31B3-4D59-9075-41DFEB8783B6Q36321174-3FDFA0A8-2CCD-4E8C-8A6A-5F4F464DBA24Q36386593-53DEDDE6-74A0-4E8A-B088-0834FEA02BF8Q36599683-C472D9E2-2952-49F4-A609-CB2070C32498Q36774595-43159FC5-7BDE-4BB3-A039-A1AD1818F1FCQ36993612-A87BF8B9-A957-4D4F-A441-96D772CF912DQ37178960-53703F70-EB6E-4FF8-A897-988FA5D2CB02Q37670238-3C00D44C-6B64-4F64-AA88-7A4485FB712BQ37690323-8DF6D76A-453D-4371-AF75-D025667B0B49Q37730859-1572912B-3245-449D-919D-60A311B21064Q37822969-A3BADE4C-F9A2-49A9-A106-A80D79363EB4Q37834316-63921FF5-8B6A-4721-98F1-5AF2ABAF680FQ37848113-10483967-50F8-4965-8E7E-AE4886C001F7Q37882500-4A229692-ED7C-4C83-9685-3BDB1E41A61EQ37884873-D2C56C51-C30A-48EA-B9B8-812B02FB6194Q37895014-36D797C8-01CC-4C74-B4B9-E13FB098AE2EQ37905624-78A08687-094E-4396-8B93-0CEB66DDF74BQ37960438-D43D86CF-4D2B-4473-A4AF-81ED23C320BFQ37978949-489B739D-44B7-45B3-888A-BB9B902B8313Q37978951-56A7C40C-B9ED-4B12-BC2E-32DB1DE95A0CQ37996857-FB4B0076-7962-4051-99A5-5238B7C823ADQ38007838-C35FBBA3-E678-4388-9BC8-5CF82F9C8099Q38079353-3BAF98FA-7F7B-437E-A071-678985469849Q38102433-1C196970-B776-4234-AD62-33F483F8FF47Q38152128-3AA81534-43CC-41D1-AAD6-DC7D41981BDEQ38180442-0649B003-97BC-4A85-B3F4-3BC1926CD0A2Q38181036-6AA46B17-2290-4E26-B544-66890106C705Q38191484-C9EC205B-B998-41F4-8AC0-39EDB9EF1BE2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adelino F Leite-Moreira
@ast
Adelino F Leite-Moreira
@en
Adelino F Leite-Moreira
@es
Adelino F Leite-Moreira
@nl
Adelino F Leite-Moreira
@sl
type
label
Adelino F Leite-Moreira
@ast
Adelino F Leite-Moreira
@en
Adelino F Leite-Moreira
@es
Adelino F Leite-Moreira
@nl
Adelino F Leite-Moreira
@sl
altLabel
A Leite-Moreira
@en
prefLabel
Adelino F Leite-Moreira
@ast
Adelino F Leite-Moreira
@en
Adelino F Leite-Moreira
@es
Adelino F Leite-Moreira
@nl
Adelino F Leite-Moreira
@sl
P106
P1153
35448017900
P21
P31
P496
0000-0001-7808-3596